Tinnie Chau

Tinnie Chau is a Vice President at Ally Bridge Group and focuses on biopharma and biotech investments. She joined Ally Bridge Group in 2015 and has since participated in the execution as well as portfolio management of all the biopharma investments of the group. Prior to joining ABG, Ms. Chau worked as a Manager at the Corporate Finance department of PwC, providing advisory services on M&A transactions across industries with a number of transactions in the healthcare sector. Ms. Chau holds a BA and MA in Biological Natural Sciences from the University of Cambridge, specialized in Pathology and Microbiology. Ms. Chau is a CFA® Charterholder.